Moreover, Kitadai et al. [40] demonstrated that the tumor-associated microvasculature in human CRC tissues contained multiple pericytes which can preserve endothelial cells from antiangiogenic treatment; therefore, inhibition of PDGFR activation combined with other antiangiogenic composites may produce therapeutic effects. Here, PDGFRB is linked to colorectal carcinoma.